Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dupilumab, ATC D11AH05 für die Zeit 01.05.2025 - 30.04.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dupilumab, ATC D11AH05 für die Zeit 01.05.2025 - 30.04.2027”. Bids close on 5 March 2027. To qualify, bidders need at least one similar completed work.
The work
Conclusion of a non-exclusive discount agreement for the pharmaceutical active substance Dupilumab for the period 01.05.2025 - 30.04.2027.
- Agreement must be for the active substance Dupilumab, ATC D11AH05.
- Contract must be submitted via email to openhouse@dak.de.
Key facts
- Contract period
- 01.05.2025 - 30.04.2027
- Evaluation
- Lowest price (L1) among technically qualified bids
- Submission
- Online, on the e-procurement portal
- Price basis
- Prescribed discounts are a contractual requirement.
What it takes to qualify
Worth a closer look
- The tender is for a 'Zulassungsverfahren' (approval procedure) which is not a formal procurement, but uses a procurement form for technical reasons.
Experience
- At least 1 similar work — Experience with pharmaceutical discount agreements (Rabattverträge) for the active substance Dupilumab.
Certifications and registrations
GST registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenSubmission via email to openhouse@dak.de.
- Vertrag mit Namen oder FirmenstempelAcknowledging contractual terms and prescribed discounts.
- Anlage 1 zum VertragTo be filled out and submitted via email.
- Anlage 2 zum Vertrag (Excel)To be filled out and submitted via email.